about
Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsivenessUptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy.Human rabies in India: epidemiological features, management and current methods of prevention.Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit.Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugsLymphocyte proliferative response and subset profiles during extended periods of chloroquine or primaquine prophylaxis.Malaria: drug use and the immune response.Emerging therapies for graft-versus-host disease.Cell mediated immunity after measles in Guinea-Bissau: historical cohort studyAntitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment.Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.Ammonium decreases human polymorphonuclear leukocyte cytoskeletal actin.Pro-inflammatory cytokines in a ruminant model: pathophysiological, pharmacological, and therapeutic aspects.Studies on the mechanism of inhibition of chemotactic tripeptide stimulated human neutrophil polymorphonuclear leucocyte superoxide production by chloroquine and hydroxychloroquine.Malaria at Humaita County, Amazonas State, Brazil. XVII--Immune response in patients with Plasmodium falciparum according to gametocytes.Effect of ampicillin and chloroquine on humoral immune response elicited by bovine albumin encapsulated in liposomes.In vitro evidence of the inhibitory capacity of chloroquine on arginase activity in sickle erythrocytes.The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters.Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients.The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?Chronic Graft-Versus-Host Disease in Children
P2860
Q28367732-A1D94462-4E08-49AA-970A-90E9BF3741F1Q33557174-328642CF-550E-472D-B69A-A3627E18F039Q33782704-DE36DD48-6DC6-4AAB-9CE1-21A5FFA4A2A9Q34604474-7FD72ECD-C905-45D5-AE7B-0712BAEF355DQ34896724-148452F0-8FA2-495C-968F-489F5970664DQ35129889-F6A1FD97-26AA-4214-B400-C3A6FF127D83Q35224460-1AEF130A-A451-496F-9434-258D7A13572BQ35602633-C3629B23-3351-4C31-885A-A2B4A144F359Q36600757-BD9AF8DD-0861-4B39-AB02-1EBC49EC78A5Q37452252-C0F80E79-031A-4BAF-97B4-4C6F60124C19Q38561490-07DAEB76-18D5-41F2-A4E2-2E1253B2BD71Q40150253-1FCC38FB-07F5-4826-9203-F7ED0E6E3EBEQ40420008-F134668F-F92C-415E-88CF-D6470F7A944AQ41198004-607D96C5-9CF3-44BA-A308-1C08E9CC7E67Q41916681-8F71A125-FC87-40F7-9A0D-CE71BE831DD8Q41939514-3753235B-0BB2-4B14-A60E-170EE2EB8992Q41942150-D82A28F4-067B-4035-AE82-7809A40F1FA9Q41944686-BFD21353-0014-4154-9A67-4B9694654142Q41945144-923329F5-D323-45DB-BAE0-F8EB9316CA51Q57254750-FBBE9288-C160-4B73-9F9B-AF92D2FD7A17Q59094154-6EB611DF-1B4C-43F1-8E5F-D8C11976B9BA
P2860
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Immunosuppressive potential of antimalarials.
@en
type
label
Immunosuppressive potential of antimalarials.
@en
prefLabel
Immunosuppressive potential of antimalarials.
@en
P1476
Immunosuppressive potential of antimalarials.
@en
P2093
G Salmeron
P E Lipsky
P356
10.1016/0002-9343(83)91266-4
P407
P577
1983-07-01T00:00:00Z